Ontology highlight
ABSTRACT: Background
The use of stem cells is considered as an appropriate source in cell therapy and tissue engineering. Differentiation of human induced Pluripotent Stem Cells (hiPSCs) to Hepatocyte-like Cells (HLCs) on mouse embryonic fibroblasts (MEFs) feeders is confronted with several problems that hinder the clinical applications of these differentiated cells for the treatment of liver injuries. Safe appropriate cells for stem cell-based therapies could create new hopes for liver diseases. This work focused on the determination of a capacity/efficiency for the differentiation of the hiPSCs into Hepatocyte-like Cells on a novel human adult bone marrow mesenchymal stem cells (hMSCs) feeder.Materials and methods
Undifferentiated human iPSCs were cultured on mitotically inactivate
SUBMITTER: Mobarra N
PROVIDER: S-EPMC4345294 | biostudies-literature | 2014 Oct
REPOSITORIES: biostudies-literature